Avid Bioservices, Inc.

Avid Bioservices, Inc. operates within the SIC 2834 universe of Pharmaceutical Preparations, offering contract development and manufacturing services that span mammalian cell and microbial biologics for biotech and pharma innovators focused on cell therapy, vaccines, and complex protein therapeutics; the profile emphasizes CIK 704562 while describing how the firm’s downstream purification, analytical, and fill/finish capabilities are tailored to emerging and mid‑sized developers who need compliant, scalable manufacturing without building their own capacity. The overview notes that regulatory scrutiny from the FDA and global agencies, along with the capital intensity of maintaining GMP suites, represents material risk—especially since Avid last filed a Form 10‑Q in December 1999, underscoring a thin public reporting stream and raising questions about current compliance documentation and market visibility. Readers concerned with evolving biosciences supply chains are invited to view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025